This inventor holds 36 USPTO granted patents and 19 published patent applications, plus 2 CIPO patents and 13 EPO patents, primarily in Cancer Therapeutics. Top assignees: Academia Sinica, National Taiwan University, Fountain Biopharma Inc.. Active years: 2007-2026.
Company Filing History:
26 out of 726 
6 out of 1,391 
3 out of 4 Years Active: 2007-2026
Areas of Expertise:
Title: Innovator Spotlight: Han-Chung Wu - Pioneering Advances in Biomedical Technology
Introduction:
Han-Chung Wu, a distinguished inventor hailing from Taipei, Taiwan, has made significant contributions to the field of biomedical technology. With a total of 34 patents to his name, Wu's innovative spirit and dedication to advancing healthcare have led to groundbreaking inventions in the realm of medical devices and pharmaceuticals.
Latest Patents:
One of Wu's latest patents involves the development of an advanced surface coating for the capture, purification, and release of biological substances. This technology is designed to enhance the detection and isolation of circulating rare cells, particularly circulating tumor cells, by leveraging a combination of nonfouling and bioactive compositions. Additionally, Wu's invention includes a novel microfluidic chip with patterned microstructures to optimize the capture rate of biological substances.
Another notable patent by Wu focuses on synthetic peptides and pharmaceutical compositions for treating thromboembolism-related diseases. By utilizing specific amino acid sequences, these biomolecules exhibit high binding affinity and specificity to thrombus, offering a targeted approach for delivering therapeutic agents to improve treatment efficacy and safety.
Career Highlights:
Throughout his illustrious career, Han-Chung Wu has collaborated with renowned institutions such as Academia Sinica and the National Taiwan University. His tenure at these esteemed organizations has not only facilitated the translation of cutting-edge research into practical applications but has also solidified Wu's reputation as a trailblazer in the field of biomedical innovation.
Collaborations:
During his professional journey, Wu has had the privilege of working alongside esteemed colleagues like Chin-Tarng Lin and Chi-Huey Wong. These collaborative efforts have fostered a culture of innovation, where diverse expertise converges to address pressing healthcare challenges and drive meaningful advancements in medical science.
Conclusion:
In conclusion, Han-Chung Wu's prolific career stands as a testament to his unwavering commitment to pushing the boundaries of biomedical technology. His groundbreaking patents and collaborative endeavors underscore Wu's impactful contributions to the field, ensuring a brighter and healthier future for generations to come.